US Patent Issued to REGENERON PHARMACEUTICALS on May 12 for "Methods of treating severe insulin resistance by interfering with glucagon receptor signaling" (New York, New Jersey Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,116, issued on May 12, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Methods of treating severe insulin resistance by interfering with glucagon receptor signaling" was invented by Jesper Gromada (Scarsdale, N.Y.), Haruka Okamoto (New York), Stephen Jaspers (Brewster, N.Y.) and Joyce Harp (Montclair, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating a patient with severe insulin resistance. The methods comprise administering to a patient in need thereof a therapeutic amount of a GCG/GCGR signaling pathway inhibitor, such that blood glucose or beta-hydroxybutyrate levels are lowered or that...